IL17A and glaucoma: Puerarin reduces high levels of IL-1β, IL-17A, and TNF-α in animal models of glaucoma. It also maintains reactive oxygen species, superoxide dismutase and malondialdehyde, NOS, and inducible NOS and NF-κB to an optimum level.